China Chlorhexidine Gluconate For Skin Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon
Short Description:
China Chlorhexidine Gluconate For Skin Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon Detail:
Major ingredient and concentration
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) is a disinfectant with Ethacridine Lactate and Dodecyl Dimethyl Benzyl Ammonium Chloride as the main active ingredients. The Ethacridine Lactate content is 0.22g/L-0.022g/L(W/V), and the Dodecyl Dimethyl Benzyl Ammonium Chloride content is 0.42g/L-0.042g/L(W/V).
Germicidal spectrum
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) can kill the microorganisms such as enteric pathogenic bacteria, pyogenic coccus, pathogenic yeast and hospital infection common germs.
Features and Benefits
1. For rinsing, cleaning and sterilizing the entire skin surface.
List of Uses
| Animal care facilities | Military bases |
| Community health centers | Operating rooms |
| Donning rooms | Orthodonist offices |
| Emergency medical settings | Outpatient surgical centers |
| Hospitals | Schools |
| Laboratories | Surgical centers |
Product detail pictures:






Related Product Guide:
Using a complete scientific top quality management program, great high-quality and fantastic religion, we win great track record and occupied this area for China Chlorhexidine Gluconate For Skin Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon, The product will supply to all over the world, such as: Los Angeles, Morocco, Greece, By continuous innovation, we will provide you with more valuable products and services, and also make a contribution for the development of the automobile industry at home and abroad. Both domestic and foreign merchants are strongly welcomed to join us to grow together.
After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.




